Call for Abstract
International Conference on Diabetes, will be organized around the theme “A Global Platform to Reunite and Raise Hands against Diabetes”
Diabetes 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Diabetes 2017
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Pathophysiology of diabetes is uncertain and depends on the type of the diabetes, there is a direct link between the hyperglycemia and physiological & behavioural responses, the signals are then sent by the brain to the pancreas to decrease its (pancreas) own functions.. Diabetes type 1 pathophysiology is the condition in which immune system attacks and destroys the insulin producing beta pancreatic cells. Diabetes type 2 is caused due to relative deficiency of insulin but not the absolute. Pathophysiology of gestational diabetes occurred by increase production of the counter-insulin hormones of pregnancy. Pathophysiology of prediabetes is similar to type 2 diabetes , two defects are insulin resistance and early beta cell failure. Genetic, immunological and metabolic components involved in pathophysiology of latent autoimmune diabetes in adults.
- Track 1-1Monogenic diabetes
- Track 1-2Exocrine pancreatic defects
- Track 1-3Diabetes type 1
- Track 1-4Diabetes type 2
- Track 1-5Gestational diabetes.
- Track 1-6Prediabetes
- Track 1-7LADA
It is estimated that about one-third diabetic people suffer from skin disorder at sometime or the other in their lives. This disorder which directly effect the skin and make the skin loose its lustre. Few skin conditions which are caused due to diabetes are like scleroderma diabeticorum, vitiligo, acanthosis nigricans, diabeticblisters. The diabetic people are even more susceptible to bacterial and fungal infections; allergic reactions to medications, insect bites or foods; dry itchy skin as a result of poor blood circulation and infections from foot injuries for people with nephropathy.
- Track 2-1Scleroderma diabeticorum
- Track 2-2Vitiligo
- Track 2-3Acanthosis nigricans
- Track 2-4Diabetic blisters
- Track 2-5Microbial infections
Diabetes can affect both the male and female reproductive systems but this should not necessarily prevent reproduction. The main risk involved regarding reproductive system is infertility and here are some reproductive syndromes and effects- vaginitis, pcos, early postmenopause, hypogonadism. Men with diabetes also have a higher chance of developing sexual and reproductive health problems like androgen (or testosterone) deficiency, erectile dysfunction, retrograde ejaculation.
- Track 3-1Infertility
- Track 3-2Vaginitis
- Track 3-3Pcos
- Track 3-4Early postmenopause
- Track 3-5Hypogonadism
Diabetes though recognised since antiquity, there were no proper treatments for it till ages. Now-a-days advanced treatments are going on in order to treat the disorder more and more effectively.
The researches are being held in a direction of early detection to the most effective advanced treatments. Advanced treatments include development of insulin pumps, insulin injections, solid dosage forms, transplantations, surgeries, targeting mst1, artificial pancreas and many more.
The advances not only being held to develop new methods but to make the most effective treatment which are affordable even by the ordinary population globally.
- Track 4-1Artificial pancreas
- Track 4-2Biomakers role in diabetes
- Track 4-3Insulin pumps
- Track 4-4Insulin injections
- Track 4-5Solid dosage forms
- Track 4-6Transplantations
- Track 4-7Surgeries
Endocrine system is a unique and essential part which helps in normal body functioning. It looks after the functions like growth of cells, organs and metabolism. Endocrine system keeps body’s hormone and secretion levels in balance.
Pancreas is the most important endocrine hormone which helps in the production of important hormones helping in maintaining the glucose levels at balance. Insulin is the most significant hormone playing role in maintaining the body’s glucose, its deficiency causes diabetes mellitus.
Hence, there exists a direct relation between endocrine system and diabetes. Some topics which can be dealt in it will be hormones and receptors, endocrine regulation, pediatric endocrine, endocrine diseases, neuroendocrinology, hormone replacement therapy.
- Track 5-1Hormones and receptors
- Track 5-2Endocrine regulation
- Track 5-3Pediatric endocrinology
- Track 5-4Endocrine diseases
- Track 5-5Neuroendocrinology
- Track 5-6Hormone replacement therapy
Genes will show the modest effect on diabetes or a related endophenotype such as insulin resistance or lower metabolic rate. The mutations in the genes or the hereditary effects are carried on to the next generation. The mutations may be like proinsulin conversion defects, insulin gene mutations, insulin receptors mutations and mitochondrial.
Understanding the role of genetics requires looking at other factors as well. Scientists have linked several gene mutations to a higher diabetes risk. Not everyone who carries a mutation will get diabetes. However, many people with diabetes have one or more of these mutations.
- Track 6-1Proinsulin conversion defects
- Track 6-2Insulin gene mutations
- Track 6-3Insulin receptors mutations
- Track 6-4Mitochondrial DNA mutations
Diabetes is a long term condition which can influence the life of a Young individual or a child and also their family and carers. It is most predominant in kids in created nations and majorly affects the development and advancement and enthusiastic prosperity of the influenced kid. Worldwide there is a clear increment in the occurrence of this malady, particularly in kids under five years old. Furthermore, this illness, if insufficiently oversaw, expands the danger of creating miniaturized scale vascular and full scale –vascular inconveniences. T1d is a standout amongst the most well-known interminable ailments starting in the adolescence and records for more than 90% of the instances of youth diabetes, with a general predominance rate of 0.2-0.5% over the Caucasoid populaces.
- Track 7-1Obesity in children
- Track 7-2Growth hormone deficiency
- Track 7-3Puberty disorders
- Track 7-4Pituitary and hypopituitarism
- Track 7-5Thyroid disorders
- Track 7-6Lifestyle
Type 1 diabetes is a chronic T-cell mediated disease that leads to the destruction of the insulin-secreting islet β-cells resulting in absolute insulin deficiency and hyperglycaemia. The clinical presentation of T1D is preceded by an asymptomatic period lasting from months to years which is characterised by autoantibodies against islet β-cell components. Insulin autoantibodies are amongst the first to appear, followed by autoantibodies to glutamic acid decarboxylase and then spreading to IA-2 (insulinoma-associated tyrosine phosphatase protein) and ZnT8 (zinc-transporter 8).
- Track 8-1Islet cell auto-antigens
- Track 8-2Immune cells
- Track 8-3Therapies using immune modulators
- Track 8-4Vaccination
Gestational diabetes is the type of diabetes that develops only during pregnancy and diagnosed. During pregnancy our body cannot cope with the extra demand for insulin production, it is because during pregnancy , the hormones of placenta may cause building of high sugar levels in the blood. Usually, pancreas can make enough of the insulin which counter acts the increased blood glucose levels, but if not it leads to gestational diabetes. There are more chances of gestational diabetes converting into type 2 diabetes mellitus.
- Track 9-1Etiology and pathogenesis
- Track 9-2Prognosis
- Track 9-3Insulin shots
- Track 9-4Managing self-care
- Track 9-5New researches
Diabetes and urologic diseases are very common health problems that markedly increase in prevalence and incidence with advancing age. Diabetes is associated with an earlier onset and increased severity of urologic diseases, resulting in costly and debilitating urologic complications. Urologic complications, including bladder dysfunction, sexual and erectile dysfunction, as well as urinary tract infections, have a profound effect on the quality of life of men and women with diabetes. Over 50% of men and women with diabetes have bladder dysfunction. Diabetes has been identified as an important independent risk factor for incontinence in several large observational studies. Current understanding of bladder dysfunction reflects a progressive condition encompassing a broad spectrum of lower urinary tract symptoms including urinary urgency, frequency, nocturia, and incontinence.
- Track 10-1Prostate enlargement
- Track 10-2Urinary inconsistency
- Track 10-3Urinary tract infections
- Track 10-4Bladder cancer
- Track 10-5Genital infections
Diabetic coma is one of a life threatening complication of diabetes which causes unconsciousness. if a diabetic individual have dangerously high blood glucose levels (hyperglycemia ) or dangerously lower blood glucose levels (hypoglycemia) can lead to a diabetic coma.
The diabetic coma is very uncommon but is very dreadful, if lapsed into, a victim will be alive but may not respond purposely to sights, sounds or other types of stimulation. If left untreated diabetic coma can be fatal.
The prospect of a diabetic coma is scary, but fortunately can be prevented if some of the necessitated precautions are taken i.e., by following a diabetes treatment plan.
- Track 11-1Diabetic ketoacidosis
- Track 11-2Diabetic hyperosmolar syndrome
- Track 11-3Hypoglycemia
The consequences of diabetes are simply far beyond our expectations, day-by-day there is a new risk involved. Excess of unused glucose in the blood is scattered all over the body where not supposed to be in. Thus, if the hyperglycemia is not maintained, it can affect every organ in the body from tip to toe but with the correct treatment and recommended lifestyle changes, the onset of complications can be prevented (or) delayed.
In addition to this there are the long term damages to our body which are like microvascular complications, macrovascular complications, cellulitis, Alzheimer’s disease, Angiopathy, diabetic ketoacidosis, hyperosmolar coma
- Track 12-1Nephropathy
- Track 12-2Microvascular complications
- Track 12-3Macrovascular complications
- Track 12-4Cellulitis
- Track 12-5Alzheimer’s disease
- Track 12-6Neuropathy
There comes lot of misconceptions about the meal of a diabetic,but when it comes to reality the one with diabetes can also consume the foods which are eaten by individuals without diabetes. There are so many diet plans for a person with diabetes and at the same time there are plenty of myths about the healthy eating. Avoiding the carbohydrates completely and depending only on protein food is not correct. At the same time, taking carbohydrates in excess than normal is also not correct. There are also so many superfoods which will help out in adding strength to your meal and body.
- Track 13-1Diabetes superfoods
- Track 13-2Diabetes: alcohol and smoking
- Track 13-3Adjusting drugs to cover overeating
- Track 13-4Giving up favourite food
- Track 13-5The plate method
The purpose of the case study and research is as clear as a crystal i.e., to develop new methods and analyse more things related to diabetes. The rodent models and other animal models help us to see the drug efficacy and help us to understand the pharmacological studies before admitting to humans. It is not safe to test the effects of a drug directly on any human model.
The more the research done more will be the best output by giving revolutionized medication, treatments, diagnosis, management and few more things.
- Track 14-1Animal model
- Track 14-2Diabetes and antipsychotic drugs
- Track 14-3Diabetes type 2 and iron stores
- Track 14-4Diabetes detection in youth
- Track 14-5Research: Anti-diabetic drugs
- Track 14-6Diabetes and homeostasis
Diabetes has become a matter of huge concern as it is a cosmopolitan disorder with an estimated 285 million diabetic, corresponding to 6.4 percentage of world’s adult population, are living with diabetes. The diabetic population is expected to explode to 438 million by 2030, corresponding to 7.8 percentage of the adult population. The rate of this disorder is on it’s highest at increase. As it is a leading problem globally there is also a gigantic demand for the diagnosis and screening, medication. The global type 2 diabetes market is set to almost double from $31.2 billion in 2015 to $58.7 billion by 2025, representing a compound annual growth rate of 6.5%, according to research and consulting firm Global Data.
The pharmaceutical business is attaining a top places in this field of medication.
- Track 15-1Insulin biosimilars development
- Track 15-2Novel paradigms